Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 18 July 2017
Sec. Gastrointestinal Cancers
Volume 7 - 2017 | https://doi.org/10.3389/fonc.2017.00151

RETRACTED: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes

Retracted

A retraction of this article was approved in:

  1. Retraction: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes

    1. Read retraction
\r\nJoe AbdoJoe Abdo1Carrie A. BertellottiCarrie A. Bertellotti2David L. CornellDavid L. Cornell2Devendra K. AgrawalDevendra K. Agrawal1Sumeet K. Mittal,*Sumeet K. Mittal1,3*
  • 1Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, United States
  • 2Department of Surgery, CHI Health Creighton University Medical Center, Omaha, NE, United States
  • 3Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Dignity Health, Phoenix, AZ, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Abdo J, Bertellotti CA, Cornell DL, Agrawal DK and Mittal SK (2017) Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes. Front. Oncol. 7:151. doi: 10.3389/fonc.2017.00151

Received: 07 April 2017; Accepted: 27 June 2017;
Published: 18 July 2017; Retracted: 24 April 2019.

Edited by:

John James Tentler, University of Colorado Denver School of Medicine, United States

Reviewed by:

Mirko Omejc, University of Ljubljana, Slovenia
Francesco Caiazza, University of California, San Francisco, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.